Through univariate Cox regression analysis, we found that FDX1 displayed a protective role in nearly all ccRCC datasets, except OS_GSE167573, which might be explained by different sample sizes and patient enrollment standards (Figure 4E). Here, FDX1 is linked to nonpapillary renal cell carcinoma.